Bioextrax AB (publ) (STO:BIOEX)

Bioextrax AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.93	17.27	13.4	27.53	8.98
Cash & Short-Term Investments	3.93	17.27	13.4	27.53	8.98
Cash Growth	-77.23%	28.87%	-51.33%	206.69%	337.54%
Accounts Receivable	0.03	-	-	0.03	0.12
Other Receivables	0.53	0.73	0.71	1.27	0.79
Receivables	0.56	0.73	0.71	1.3	0.91
Prepaid Expenses	1.06	0.29	0.29	0.34	0.22
Other Current Assets	-	0.91	0.36	1.23	1.31
Total Current Assets	5.54	19.2	14.76	30.4	11.42
Property, Plant & Equipment	5.84	6.82	7.76	7.49	1.22
Other Long-Term Assets	13.34	2.98	-	0.03	-
Total Assets	24.73	29	22.52	37.92	12.64
Accounts Payable	1.18	1.53	1.33	3.56	2.22
Accrued Expenses	1.6	0.84	0.44	0.98	1.04
Current Income Taxes Payable	0.08	0.1	0.14	0.13	0.06
Current Unearned Revenue	-	-	-0.59	0.89	1.41
Other Current Liabilities	0.66	0.47	0.67	0.6	0.41
Total Current Liabilities	3.51	2.94	1.98	6.15	5.14
Total Liabilities	3.51	2.94	1.98	6.15	5.14
Common Stock	2.02	1.97	1.47	1.28	0.74
Additional Paid-In Capital	12.14	22.32	9.86	41.73	15.96
Retained Earnings	6.68	1.73	9.21	-11.24	-9.2
Comprehensive Income & Other	0.38	0.05	-	-	0
Shareholders' Equity	21.22	26.06	20.54	31.77	7.5
Total Liabilities & Equity	24.73	29	22.52	37.92	12.64
Net Cash (Debt)	3.93	17.27	13.4	27.53	8.98
Net Cash Growth	-77.23%	28.87%	-51.33%	206.69%	337.54%
Net Cash Per Share	0.10	0.52	0.51	1.63	0.67
Filing Date Shares Outstanding	40.03	39.12	29.23	25.46	14.75
Total Common Shares Outstanding	40.03	39.12	29.23	25.46	14.75
Working Capital	2.03	16.26	12.78	24.25	6.28
Book Value Per Share	0.53	0.67	0.70	1.25	0.51
Tangible Book Value	21.22	26.06	20.54	31.77	7.5
Tangible Book Value Per Share	0.53	0.67	0.70	1.25	0.51
Machinery	-	9.99	9.77	8.64	1.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.